Schizophrenia is a common disease with a 1% prevalence in the general population and has a strong genetic component. Although many candidate susceptibility genes have been suggested to carry modest risk for schizophrenia in human genetic studies, no functional mutations have been identified and replication studies have been inconsistent. In contrast, disrupted-in-schizophrenia (DISC1) was identified as a balanced chromosome translocation on chromosome 1q42 in a large Scottish schizophrenia family. 1, 2 The t(1; 11) translocation seems to be the causal genetic lesion, with 70% penetrance for major mental illness in this family. Therefore, an understanding of the precise genetic lesion in this Scottish family will be valuable for molecular biologists to unravel the underlying molecular mechanism of the disease. Our previous analysis found that a novel gene, termed Boymaw, was disrupted by the translocation on chromosome 11, and suggested the generation of two fusion transcripts between Boymaw and DISC1 genes. 3 To understand the potential functions of the Boymaw gene, we conducted a 5 0 -rapid amplification of the cDNA ends (5 0 -RACE) of Boymaw transcripts in human brain (Ambion, Human Thalamus Brain Total RNA cat # AM6762). A novel exon E1b was identified, which is present only in human brain and not in lymphoblastoid cells (Figure 1a) . Surprisingly, the Boymaw E1b is overlapped by the 5 0 untranslated region of CHORDC1 mRNA (an isoform in human thalamus, accession: AK290231) in a cis-natural antisense orientation (Figure 1b) . To examine whether the Boymaw E1b was transcribed in human thalamus, we conducted an RT-PCR analysis of total RNA in human thalamus (Ambion) (Figure 1c ). Boymaw E1b was not only transcribed, but also alternatively spliced with other exons to form several different Boymaw transcripts (Figure 1d ). However, exon 3 is not included in any of these transcripts. CHORDC1, a circadian gene in the brain, 4 has been reported to physically interact with the ATPase domains of both HSP90 and protein phosphatase 5 proteins, which are involved in stress responses, homeostatic regulation and regulation of glucocorticoid receptors.
5-7 cis-natural antisense transcripts (cis-NAT) have been reported to inhibit the expression of sense transcripts by a novel gene regulatory network that is not well conserved between species. [8] [9] [10] An inherited form of a-thalassemia was reported to be caused by an inhibition of the expression of the hemoglobin a-2 gene through a cis-NAT. 11 Therefore, the cis-natural antisense RNA from the Boymaw gene could inhibit CHORDC1 expression. Unfortunately, the absence of the Boymaw gene in the mouse genome prevented a straightforward examination of this regulation.
After the identification of the brain-specific Boymaw mRNA, we generated the fusion transcripts between Boymaw and DISC1 genes to mimic the effects of translocation in the Scottish family ( Figure  2a (b) Western blot analysis of protein expression in HEK293 cells. The cells were harvested 2 days after transfection, and proteins (supernatant fraction) were extracted using the same lysis buffer in the presence of 2% sarkosyl (13) . The pellet was collected and solubilized in SDS loading buffer. Equal amounts of proteins from each sample were loaded for western blot analysis. The control (C) was HEK293 cells transfected with pcDNA3.1-zeocin vector only. BD13 proteins were expressed abundantly in the supernatant fraction, and no detectable expression of BD7 was observed. In contrast, BD7 was detected only in the insoluble fraction (pellet). (c) Localization of BD13 and DB7 proteins in hippocampal neuronal cells. BD13 was expressed abundantly in the cytoplasm, and DB7 was much less expressed and formed 'punctate' staining in cytoplasm and neuronal processes.
an examination of their expression. Surprisingly, the DISC1-Boymaw chimeric proteins (DB7) were insoluble (found only in the pellet), whereas the proteins from the Boymaw-DISC1 fusion transcripts (BD13) are abundant and found almost exclusively in the supernatant (Figure 2b ). To further examine the subcellular localization of these proteins, the constructs were transfected into HCN-B27 cells, rat hippocampal neuronal cell lines.
12 DISC1-Boymaw chimeric proteins (DB7) showed 'punctate' staining, whereas proteins generated from BD13 seemed abundant and diffuse in the cytoplasm of hippocampal neuronal cells (Figure 2c ). Insoluble DISC1 proteins have been reported in the postmortem brains of patients with schizophrenia, bipolar mania and major depression. 13 The insolubility of DISC1 proteins could therefore be the common pathological defects that disrupt the normal functions of neuronal cells. On the other hand, the generation of C-terminal DISC1 proteins from Boymaw-DISC1 fusion transcripts could also contribute to the pathogenesis of psychiatric disorders, given that the overexpression of DISC1 C-terminal fragments has been shown to impair memory and sociability in a transgenic mouse model. 14 On the basis of a combination of these findings, we suggest that the translocation in the Scottish family could have multiple effects beyond the originally identified disruption of the DISC1 gene. First, the disruption of the Boymaw gene by chromosome translocation could potentially disorder stress response by deregulating CHORDC1 expression. Second, the generation of insoluble DISC1-Boymaw proteins and the expression of C-terminal DISC1 proteins could exert important effects in the pathogenesis of schizophrenia and other psychiatric disorders. An investigation of these hypotheses is merited in future studies. Human neural progenitor cells (NPCs) offer a new strategy for de novo modelling of neurodevelopment and neuropsychiatric disease. 1 They can be derived from numerous stem cell types including embryonic and adult stem cells, or isolated from neurogenic tissues of the human central nervous system. As lineage-restricted cells, NPCs are self-renewing and easily differentiated to neurons, astrocytes and oligodendrocytes using methods that emulate in vivo development and neural cell replacement. Genetically modified cells can be generated to exhibit disease-related phenotypes and aberrant mechanisms for cellular and molecular analysis. Furthermore, they have the potential to be used as tools for early phase drug discovery by predicting in vivo drug response through in vitro cell-based assayology of drug candidates.
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Disrupted-in-schizophrenia 1 (DISC1) is a risk factor for a variety of psychiatric and mental disorders, with mutant forms likely causing an overall loss of function in schizophenia. [2] [3] [4] Non-human
